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Abstract
Background: Silica nanoparticles (SiNPs) have numerous beneficial properties and are extensively used in
cosmetics and food industries as anti-caking, densifying and hydrophobic agents. However, the increasing
exposure levels experienced by the general population and the ability of SiNPs to penetrate cells and tissues
have raised concerns about possible toxic effects of this material. Although SiNPs are known to affect the
function of the airway epithelium, the molecular targets of these particles remain largely unknown. Given that
SiNPs interact with the plasma membrane of epithelial cells we hypothesized that they may affect the
function of Transient Receptor Potential Vanilloid 4 (TRPV4), a cation-permeable channel that regulates
epithelial barrier function. The main aims of this study were to evaluate the effects of SiNPs on the activation
of TRPV4 and to determine whether these alter the positive modulatory action of this channel on the ciliary
beat frequency in airway epithelial cells.
Results: Using fluorometric measurements of intracellular Ca2+ concentration ([Ca2+]i) we found that SiNPs inhibit
activation of TRPV4 by the synthetic agonist GSK1016790A in cultured human airway epithelial cells 16HBE and in
primary cultured mouse tracheobronchial epithelial cells. Inhibition of TRPV4 by SiNPs was confirmed in intracellular
Ca2+ imaging and whole-cell patch-clamp experiments performed in HEK293T cells over-expressing this channel. In
addition to these effects, SiNPs were found to induce a significant increase in basal [Ca2+]i, but in a TRPV4-independent
manner. SiNPs enhanced the activation of the capsaicin receptor TRPV1, demonstrating that these particles have a
specific inhibitory action on TRPV4 activation. Finally, we found that SiNPs abrogate the increase in ciliary beat
frequency induced by TRPV4 activation in mouse airway epithelial cells.
Conclusions: Our results show that SiNPs inhibit TRPV4 activation, and that this effect may impair the positive
modulatory action of the stimulation of this channel on the ciliary function in airway epithelial cells. These findings
unveil the cation channel TRPV4 as a primary molecular target of SiNPs.
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Background
Synthetic amorphous SiNPs are extensively used due to its
interesting physico-chemical properties, low cost and rela-
tively easy production. This material has many applications
in industrial manufacturing, cosmetics, biotechnology,
medicine, and food, pharmaceutical and chemical industries
[1–4]. SiNPs are widely used in consumer products and as
a consequence, human exposure to this nanomaterial has
highly increased. However, there is very little information
available about the risks associated to the exposure to this
nanomaterial [5].
It is known that SiNPs can penetrate cells, interacting
with the plasma membrane, intracellular structures and
organelles, thereby posing potential health threats [6–8].
The toxicity generated by nanoparticles has been
related to an increased generation of reactive oxygen
species (ROS) [9, 10]. This results in oxidative stress,
mitochondrial perturbation and the generation of in-
flammatory mediators leading to cell dysfunction and
apoptosis [2, 3, 11–19].
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One of the main entry pathways of nanoparticles into
the body is the epithelium of the airways. In addition to
its function in gas exchange, the respiratory epithelium
protects the body against hazardous environmental sub-
stances and pathogens, constituting an active diffusion
barrier, and supporting the mechanisms of mucociliary
clearance and recruitment of inflammatory cells [20–22].
Several cellular responses to SiNPs in the airways have
been reported. Rabiolli et al. demonstrated that SiNPs in-
duce lung inflammation through the stimulation of IL-1β
production by alveolar macrophages [23]. Skuland et al.
showed evidence of pro-inflammatory responses induced
by amorphous SiNPs in lung epithelial cells [24]. Delaval
et al. reported that SiNPs pre-exposure in pneumonia
induced by Pseudomonas aeruginosa increases lung
permeability and enhance mortality [25], and Kasper et al.
showed inflammatory and cytotoxic responses such as
DNA damage, hypoxia and ER-stress induced by SiNPs in
an alveolar-capillary co-culture model [18].
However, little is known about the influence of SiNPs
on specific molecular targets and cell signaling events,
especially at the level of the plasma membrane. In this
study we hypothesized that SiNPs may affect the func-
tion of TRPV4, a Ca2+-permeable cation channel
expressed in airway epithelial cells. This channel plays a
role in the transduction of physical and chemical stimuli
into Ca2+ signals that regulate ciliary beat frequency and
mucociliary transport [26, 27]. Moreover, TRPV4 con-
tributes to the barrier integrity in the lung and to the
regulation of endothelial and epithelial permeability [28,
29], and has been implicated in the modulation of the
respiratory function and proposed as target for the treat-
ment of respiratory diseases such chronic obstructive
pulmonary disease and asthma [30–33].
We used intracellular Ca2+ imaging and patch-clamp
to evaluate the effects of SiNPs on TRPV4 activation.
We found that SiNPs inhibit the activation of native
TRPV4 channels in human and mouse airway epithe-
lial cells, as well as recombinant TRPV4 in the heter-
ologous expression system HEK293T. Furthermore,
SiNPs inhibited the TRPV4-mediated increase in cil-
iary beat frequency in mouse airway epithelial cells.
TRPV4 emerges therefore as a defined molecular tar-
get of SiNPs, with possible deleterious consequences
for epithelial barrier function.
Methods
Ludox® SiNPs
SM30 Ludox® SiNPs were purchased from Sigma-Aldrich
(Bornem, Belgium) as the commercial source of 30% wt
suspension in H2O. For the biological experiments the
nanoparticle suspension was diluted to the desired
concentrations in Krebs solution containing (in mM):
150 NaCl, 6 KCl, 1 MgCl2, 1.5 CaCl2, 10 glucose, 10 4-
(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)
and titrated to pH 7.4 with NaOH.
Dynamic Light Scattering (DLS) and Zeta potential
The stock suspension of SiNPs particles was diluted in
water to 30 μg/ml. DLS and Zeta potential measurements
were performed with a Brookhaven 90 Plus/ZetaPlus
instrument (Brookhaven Instruments Ltd, Redditch, UK).
DLS measurements were performed using a NanoParticle
Size Distribution Analyser (scattering angle 90 u, wave-
length 659 nm, power 15 mW). Correlation functions
were analyzed using the Clementine package (maximum
entropy method) for Igor Pro 6.02A (WaveMetrics,
Portland, OR, USA).
Zeta potential measurements were done by applying
electrophoretic light scattering. A primary and reference
beam (659 nm, 35 mW), modulated optics and a dip-in
electrode system were used. The frequency shift of scat-
tered light (relative to the reference beam) from a charged
particle moving in an electric field is related to the electro-
phoretic mobility of the particle. The Smoluchowski limit
was used to calculate the Zeta potential from the electro-
phoretic mobility.
Transmission Electron Microscopy (TEM)
Suspensions (5 μl of stock suspension and 30 μg/ml) of
the SiNPs particles were applied on formvar-coated cup-
per mesh grids (drop on grid). After drying overnight
(25 °C in the dark), the particles were characterized by
TEM (JEOL JEM-1200 EX-II, Tokyo, Japan).
Endosafe-PTS
We used the Endosafe-PTS LAL assay for FDA-licensed
endotoxin detection. The cartridges contained four chan-
nels to which LAL reagent and a chromogenic substrate
were applied. Two of these channels contained also an
endotoxin spike that served as positive control. The sensi-
tivity of the assay was 0.05 EU/ml.
Cell culture
Human bronchial epithelial cell line, 16HBE, were grown
in Dulbecco's modified Eagle's medium: nutrient mixture
F-12 (DMEM/F-12) containing 5% (v/v) fetal calf serum
(FCS), 2 mM L-glutamine, 2 U/ml penicillin and 2 mg/
ml streptomycin at 37 °C in a humidity-controlled incu-
bator with 5% CO2 and were seeded on 18-mm glass
cover slips coated with poly-L-lysine (0.1 mg/ml).
Human embryonic kidney cells, HEK293T, were grown
in Dulbecco's modified Eagle's medium (DMEM) contain-
ing 10% (v/v) fetal calf serum (FCS), 2 mM L-glutamine, 2
U/ml penicillin, 1% non-essential amino acids (Invitrogen,
Erembodegem - Aalst, Belgium) and 2 mg/ml strepto-
mycin at 37 °C in a humidity-controlled incubator with
10% CO2 and were seeded on 18-mm glass cover slips
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coated with poly-L-lysine (0.1 mg/ml). For intracellular
Ca2+ imaging and patch-clamp experiments, HEK293T
cells were transiently transfected with mouse TRPV4 in
the CAGGSM2/Ires/GFP/R1R2 vector, using Mirus
TransIT-293 (Mirus Corporation; Madison, WI, USA). In
all experiments, transfected cells were identified by green
fluorescent protein (GFP) expression.
Animals
C57Bl/6J male mice from 8-12 weeks old were used for
the experiments. The animals were maintained under
standard conditions with a maximum of four animals
per cage on a 12-h light/12-h dark cycle and with food
and water ad libitum.
Culture of mouse tracheal epithelial cells
Mouse tracheal epithelial cells (mTEC) were isolated fol-
lowing the protocol described by Lam et al. [32], and
seeded on 18-mm glass cover slips coated with collagen
solution containing 50 μg/ml collagen (type I solution
from rat tail, Sigma-Aldrich). Cells were grown for 2-3
days in the appropriate proliferation medium and main-
tained at 37 °C in a humidity-controlled incubator with
5% CO2.
Intracellular Ca2+ imaging experiments
Ca2+-imaging experiments were conducted with the ratio-
metric fluorescent indicator Fura-2 acetoxymethyl (AM)
ester. Cells were incubated with 2 μM Fura-2 AM for 30
min at 37 °C. Bath solutions were perfused by gravity via a
multi-barreled pipette tip with a single outlet of 0.8 mm
inner diameter. This system allows full exchange of the
medium bathing the recorded cell in less than 2-4 s. For
recording in control condition cells were rinsed with
Krebs solution. The [Ca2+]i was monitored through the ra-
tio of fluorescence measured upon alternating illumin-
ation at 340 and 380 nm using an MT-10 illumination
system and the xcellence pro software (Olympus, Planegg,
Germany). All experiments conducted in the native
16HBE and mTEC cells were performed at 35 °C. Experi-
ments in HEK293T cells were performed at 25 °C because
at 35 °C the TRPV4-transfected cells were heavily over-
loaded with Ca2+ in basal condition.
The concentration-dependent effects of SiNPs on basal
[Ca2+]i of 16HBE cells was fit with a Hill function of the
form:
Δ Ca2þ
  ¼ Δ Ca2þ Max
SiNPs½ H
SiNPs½ H þ ECH50
where Δ[Ca2+]Max is the maximal amplitude of the re-
sponse to SiNPs, [SiNPs] is the concentration of SiNPs,
EC50 is the effective concentration and H is the Hill
coefficient.
The concentration-dependent effects of SiNPs on the
Ca2+ responses to the TRPV4 agonist GSK1016790A
were fit with a Hill function of the form:
Δ Ca2þ
  ¼ Δ Ca2þ Max−Δ Ca2þ
 
Inf
  SiNPs½ H
SiNPs½ H þ ICH50
þ Δ Ca2þ Inf
where Δ[Ca2+]Max is the amplitude of the response in
the absence of SiNPs, Δ[Ca2+]Inf is the amplitude of the
response the presence of saturating concentrations of
SiNPs, [SiNPs] is the concentration of SiNPs, IC50 is the
effective inhibitory concentration and H is the Hill
coefficient.
Patch-clamp experiments
Whole-cell voltage-clamp recordings were performed at
35 °C with standard patch pipettes (2-3 MΩ resistance)
pulled using a DMZ-Universal puller (Zeitz Instruments,
Augsburg, Germany). The pipette solution contained (in
mM): 2 ATPNa2, 5 EGTA, 10 HEPES, 1 MgCl2, 135
CsCl2 (292 mOsm/kg; pH 7.2, adjusted with CsOH). For
perforated patch experiments, 250 μg/ml of Amphoteri-
cin B was added to the pipette solution and data were
collected after the access resistance reached stable values
of ~15 MΩ.
An Ag-AgCl wire was used as reference electrode. The
cover slips with cells were placed in the stage of an
inverted microscope (Olympus IX70, Tokyo, Japan) and
stabilized for a few minutes in Krebs solution, containing
(in mM): 150 NaCl, 6 KCl, 1 MgCl2, 1.5 CaCl2, 10 glucose,
and 10 HEPES and titrated to pH 7.4 with NaOH. The
control bath solution was kept at room temperature and
contained (in mM): 140 NaCl, 1.3 MgCl2, 2.4 CaCl2, 10
HEPES, 10 glucose and (311 mOsm/kg; pH 7.4, adjusted
with NaOH). Bath solutions were perfused by gravity via a
multi-barreled pipette. A bath solution in which all cations
were isotonically substituted by NMDG+ (N-methyl-D-
glucamine) was used to monitor the size of the leak cur-
rents during the patch-clamp recordings [34]. Current sig-
nals were recorded using the patch-clamp technique by
using an EPC-7 (LIST Electronics, Darmstadt, Germany)
amplifier and the Clampex 9.0 software program (Axon
instruments, Sunnyvale, CA, USA). Currents were ac-
quired at 10 kHz, filtered at 2 kHz, and stored for off-line
analysis on a personal computer. In order to minimize
voltage errors, the series resistance was compensated by
30-50% and the capacitance artifact was reduced using the
amplifier circuitry. Membrane TRPV4 currents were elic-
ited by a 600 ms long voltage ramp from -100 mV to
+100 mV every 5 s with a holding potential of 0 mV.
Patch-clamp data was analyzed with the WinASCD
software written by Dr. Guy Droogmans and Origin 7.0
(OriginLab Corporation, Northampton, MA, USA). The
Sanchez et al. Particle and Fibre Toxicology  (2017) 14:43 Page 3 of 14
concentration dependence of TRPV4 current amplitude
was fit with a Hill function of the form:
ΔI ¼ ΔIMax−ΔIInf
  SiNPs½ H
SiNPs½ H þ ICH50
þ ΔIInf
where ΔIMax is the current density increase in the ab-
sence of SiNPs, ΔIInf is the current density increase in the
presence of saturating concentrations of SiNPs, [SiNPs] is
the concentration of SiNPs, IC50 is the effective inhibitory
concentration and H is the Hill coefficient.
Ciliary beat frequency (CBF) measurements
CBF was measured in primary cultures ciliated cells using
with a high-speed digital imaging system as previously
described [26]. Briefly, phase-contrast images (512 × 512
pixels) were collected at 120–135 frames per second with
a high speed CCD camera using a frame grabber (Infai-
mon, Barcelona, Spain) and recording software from
Video Savant (IO Industries, London, ON, Canada). The
ciliary beat frequency was determined from the frequency
of variation in light intensity of the image as a result of re-
petitive motion of cilia.
Reagents
All chemicals were purchased from Sigma-Aldrich (Bornem,
Belgium).
Statistics
Data are given as mean ± standard error of the mean.
Comparisons tests are indicated in the text were ap-
propriate. Statistical significance were taken at P < 0.05
or P < 0.01.
Results
Characterization of the SM30 Ludox® SiNPs
Analysis of the SiNPs by DLS showed a single popula-
tion of average size 10.2 nm (P10: 8.1 nm - P90: 11.8).
The particles had a Zeta-potential of 20 ± 3 mV. TEM
analysis of undiluted samples showed large aggregates,
but in the diluted samples only a few aggregates could
be found, and the particles appeared as spherical entities.
No endotoxin contamination was detected in 30 μg/ml
SiNPs dilutions.
Silica NPs inhibit TRPV4 activation in cultured human
airway epithelial cells
To determine whether SiNPs modulate native human
TRPV4 channels we used fluorometric measurements of
[Ca2+]i in cultured human bronchial epithelial 16HBE cells,
which were reported to express this channel [34–37]. We
found that 10 nM GSK1016790A induced intracellular Ca2
+ responses in 100% (n = 333) of these cells, indicating for a
prevalent functional expression of TRPV4 (Fig. 1a).
Extracellular application of SiNPs increased the basal
[Ca2+]iin a concentration-dependent manner (Fig. 1b-d),
which was characterized by an EC50 of 99 ± 13 μg/ml, a
Hill coefficient of 0.71 ± 0.07 and a maximal response of
0.6 ± 0.1 μM (Fig. 1e). To evaluate the effect of SiNPs on
TRPV4 activation we compared the amplitude of the [Ca2
+]i responses measured 2 min after application of 10 nM
GSK1016790A, in the absence and in the presence of
nanoparticles. SiNPs induced a concentration-dependent
inhibition of the responses to GSK1016790A, with an IC50
of 130 ± 40 μg/ml and a Hill coefficient of -1.2 ± 0.4 (Fig.
1f). Of note, SiNPs failed to completely abolish the re-
sponse to GSK1016790A up to a concentration of 3000
μg/ml, leaving ~30% of the response to the channel
agonist.
SiNPs increase basal [Ca2+]i in a TRPV4-independent
manner
It has been previously suggested that TRPV4 is impli-
cated in intracellular Ca2+ responses to SiNPs in a cell
subpopulation of the GT1-7 neuron-derived cell line
[38]. Thus, we tested whether TRPV4 is involved in the
[Ca2+]i increases triggered by SiNPs in 16HBE cells.
First, we determined whether the amplitude of the re-
sponses to SiNPs correlated with the amplitude of the
responses to GSK1016790A, i.e., with the level of func-
tional expression of TRPV4 in each cell. We found that
this was not the case, with correlation values (R) of
0.074 (Fig. 2a). This value is lower than those we have
previously found for the correlation between the ampli-
tudes of responses to very low and high concentrations
of GSK1016790A [39]. The average increase in basal
[Ca2+]i elicited by 300 μg/ml SiNPs in 16HBE was not
significantly different in the absence (0.40 ± 0.04 μM)
and in the presence of the specific TRPV4 blocker
HC067047 [40] (0.43 ± 0.05 μM; P = 0.64; Fig. 2b).
These data demonstrate that TRPV4 does not mediate
the basal Ca2+ responses triggered by SiNPs.
An increase in basal [Ca2+]i does not inhibit a subsequent
TRPV4 activation
Next, we determined if an increase in basal [Ca2+]i such
as that induced by SiNPs could cause a decrease in
TRPV4 activation. For this we tested the effect of extra-
cellular application of ATP on a subsequent response of
16HBE cells to 10 nM GSK1016790A. We found that
ATP triggered a robust intracellular Ca2+ signal, and that
this did not reduced, but rather increased the amplitude
of the TRPV4 response measured at 2 min of
GSK1016790A application (0.54 ± 0.05 vs. 0.82 ± 0.08 in
control and after ATP application, respectively, P =
0.005; Fig. 3a, b).
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SiNPs inhibit TRPV4 activation in mouse tracheal epithelial
(mTEC) cells
In order to determine whether the effect of SiNPs is
conserved for native mouse TRPV4 we used primary
cultured mouse tracheal epithelial cells. Application of
10 nM GSK1016790A triggered intracellular Ca2+ sig-
nals in 94.4% (187 out of 198) of these cells (Fig. 4a),
consistent with a previous report on the functional ex-
pression of TRPV4 channels in these cells [26]. SiNPs
induced a concentration-dependent inhibition of the
responses to GSK1016790A, with an IC50 of 1.2 ± 0.2
μg/ml and a Hill coefficient of -1.1 ± 0.3 (Fig. 4b-d).
As observed in 16HBE cells, application of SiNPs at
high concentrations did not abolish the response to
the TRPV4 agonist, but left ~20% of the maximal
response.
SiNPs inhibit activation of recombinant TRPV4
To test whether SiNPs inhibit activation of TRPV4 in a
heterologous expression system we performed intracel-
lular Ca2+ imaging experiments in HEK293T cells tran-
siently transfected with the mouse channel isoform.
These cells showed a wide spectrum of basal [Ca2+]i, a
fact that we ascribe to the variable efficacy of TRPV4
Fig. 1 SiNPs inhibit TRPV4 activation in 16HBE cells. a, b, c, d Effects of the TRPV4 agonist GSK1016790A on the [Ca2+]i in the absence (a, n = 333)
or in the presence of SiNPs 10 μg/ml (b, n = 234), 100 μg/ml (c, n = 163) and 1000 μg/ml (d, n = 114). The thick continuous traces correspond to
the average responses and the thin dashed traces correspond to the mean plus/minus the standard errors. The dashed lines and black arrows
indicate the amplitude of the average Ca2+ responses recorded after 2 min application of GSK1016790A, with respect to the immediate previous
basal [Ca2+]i. The gray arrows point to the peak of basal Ca
2+ responses to SiNPs. e Concentration dependence of the maximal amplitude of basal
Ca2+ responses induced by the application of SiNPs. f Average amplitude of responses to 10 nM GSK1016790A when applied in the presence of
SiNPs at different concentrations. In (e) and (f) the solid lines represent fits with Hill functions (see Methods)
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transfection in each cell and the constitutive activity of
this Ca2+-permeable channel. Analysis of the distribu-
tion of these values suggested the presence of two cell
populations, which could be divided using a cutoff
value of 250 nM. Both groups of cells responded ro-
bustly to 10 nM GSK1016790A (Fig. 5a).
Application of SiNPs induced a concentration-
dependent increase of [Ca2+]i in cells with low basal
[Ca2+]i (Fig. 5b, c), an effect reminiscent of that we
observed in 16HBE cells (Fig. 1b-e). In contrast, SiNPs
reduced [Ca2+]i in cells with high basal Ca
2+ levels (Fig.
5b, c), which may be an indicative of an inhibitory effect
of the SiNPs on the basal activity of TRPV4. In both
groups SiNPs reduced the response to GSK1016790A
with an IC50 of 1.44 ± 0.06 μg/ml and a Hill coefficient
of -2.0 ± 0.16 (Fig. 5d). Again, we found that application
of SiNPs at high concentrations left ~30% of the re-
sponse to the TRPV4 agonist.
Next, we determined whether SiNPs inhibit the acti-
vation of TRPV4 by another synthetic chemical agonist,
4α-phorbol 12,13-didecanoate (4αPDD). We found that
SiNPs (300 μg/ml) strongly inhibited the response to
4αPDD (Fig. 5e, f ), showing that their effect is not ex-
clusive for channel activation with GSK1016790A.
In all experiments described above we allowed suffi-
cient time for the SiNPs effects on basal [Ca2+]i to
roughly reach a steady-state (~10 min). However, we
were also interested in estimating the time required for
these particles to reduce TRPV4 activation. Thus, we
performed a series of experiments in which we varied
the time of application of SiNPs before stimulating
TRPV4 with 10 nM GSK1016790A. This time varied
from zero (simultaneous application of SiNPs and
GSK1016790A) to 10 min. We found that TRPV4 re-
sponses were significantly smaller in the presence of
SiNPs (P < 0.05) and that the strength of inhibition was
not significantly different when comparing across the
various pre-application times tested (Tukey's Multiple
Comparison Test; Fig. 6). This indicates that the inhibi-
tory action of these particles on TRPV4 activation was
prior to the full activation of TRPV4 by GSK1016790A
(~2 - 3 min).
Fig. 2 TRPV4 does not mediate the increase in basal [Ca2+]i induced by SiNPs in 16HBE cells. a Lack of correlation of the amplitudes of the intracellular
Ca2+ responses to 300 μg/ml SiNPs and to the TRPV4 agonist GSK047067 (10 nM). b Effect of 300 μg/ml SiNPs in the absence (Control) and in the
presence of the TRPV4 inhibitor HC067047 (10 μM). The lines represent average responses of 120 and 164 cells in control and HC067047, respectively
Fig. 3 Stimulation of 16HBE cells with ATP potentiates a subsequent activation of TRPV4. a, b Effects of the TRPV4 agonist GSK1016790A on the
[Ca2+]i of HEK293T cells transfected with mouse TRPV4, in control (a, n = 253) or after extracellular perfusion of ATP (b, n = 266). The thick
continuous traces correspond to the average responses and the thin dashed traces correspond to the mean plus/minus the standard errors
Sanchez et al. Particle and Fibre Toxicology  (2017) 14:43 Page 6 of 14
To directly test the effects of SiNPs on TRPV4 we per-
formed whole-cell patch-clamp experiments (Fig. 7a, b).
We recorded currents during the application of repetitive
voltage ramps applied from -100 to +100 mV. Application
of SiNPs at increasing concentrations had a tendency to
augment the amplitude of basal currents, but this was
statistically significant only at 300 μg/ml (Fig. 7c). To
evaluate the effect of SiNPs on TRPV4 we compared the
amplitude of the current responses measured 1 min after
application of 10 nM GSK1016790A, in the absence and
in the presence of nanoparticles (Fig. 7a and b). The re-
sponse to GSK1016790A was significantly reduced when
this compound was applied in the presence of SiNPs. This
effect was dependent on the concentration of SiNPs, and
was characterized by an IC50 of 2.4 ± 0.5 μg/ml, a Hill co-
efficient of -0.54 ± 0.07 and minimum value of 0.7 ± 0.2
pA/pF, for the currents measured at -75 mV (Fig. 7d).
To test whether the inhibition of TRPV4 activation is
observed also in experimental conditions in which the
intracellular milieu is better preserved we performed
perforated patch-clamp experiments using Amphotericin
B in the patch pipette (Fig. 8a, b). We found that extra-
cellular application of SiNPs (30 μg/ml) significantly
reduced the response of TRPV4 current to 10 nM
GSK1016790A (Fig. 8c).
Effects of SiNPs on the capsaicin receptor TRPV1
Next, we performed intracellular Ca2+ imaging experi-
ments to determine the effects of 300 μg/ml SiNPs on
the response of TRPV1 to its specific agonist capsaicin
(1 μM). TRPV1 is the founding member of the vanilloid
subfamily of TRP channels, and its amino acid sequence
has 42.3% identity and 58.9% similarity with that of
TRPV4 (EMBOSS Needle application for Protein Align-
ment; http://www.ebi.ac.uk/Tools/psa/emboss_needle/
help/index-protein.html). We found that the responses
of HEK293T cells transfected with mouse TRPV1 to cap-
saicin were increased by 44% in the presence of SiNPs (P
= 0.0011; Fig. 9).
SiNPs inhibit TRPV4-mediated increase of ciliary beat fre-
quency in airway epithelial cells
The cilia of airway epithelial cells are considered to be
sensory organelles with the ultimate function of sweep-
ing mucous loaded with pollutants and pathogens out of
the airways. TRPV4 is expressed in the cilia, and has
been proposed to regulate mucociliary transport by
transducing physical and chemical stimuli such as vis-
cosity or fluid tonicity into a Ca2+ signal that enhances
ciliary beat frequency [26, 27, 41, 42]. Thus, to deter-
mine whether the inhibition of TRPV4 by SiNPs has a
Fig. 4 SiNPs inhibit TRPV4 activation in mTEC. a, b, c, d Effects of the TRPV4 agonist GSK1016790A on the [Ca2+]i in the absence (a, n = 127) or in
the presence of SiNPs 1 μg/ml (b, n = 243) and 3000 μg/ml (c, n = 349). The thick continuous traces correspond to the average responses and
the thin dashed traces correspond to the mean plus/minus the standard errors. d Average amplitude of responses to 10 nM GSK1016790A when
applied in the presence of SiNPs at different concentrations. The solid line represents a fit with a Hill function (see Methods)
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correlate at the level of a cellular function, we deter-
mined the effects of these nanoparticles on the response
of cilia to GSK1016790A. Application of 10 nM
GSK1016790A in control condition induced a significant
26 ± 3% increase in CBF (n = 22; P < 10-4; paired t test;
Fig. 10a). This effect was very similar to that reported by
Alenmyr et al. in human nasal epithelial cells [43]. Ap-
plication of 300 μg/ml SiNPs modestly reduced the basal
CBF (~10%; n = 34; P < 10-4; paired t test; Fig. 10b) and
fully abrogated the response to GSK1016790A (n = 34;
P = 0.41; paired t test between CBF immediately before
and after 3 min application of the TRPV4 agonist).
Washout of SiNPs in the presence of the TRPV4 agon-
ist led to an increase in CBF (n = 34; P = 0.014; paired
t test). Because SiNPs reduced the basal CBF only
slightly and fully inhibited the response to GSK1016790A
we argue that the latter effect was mainly mediated by in-
hibition of TRPV4, and not by an unspecific effect of the
nanoparticles on other mechanisms regulating the CBF.
Discussion
Despite the current advances in the characterization of
the toxicological properties of SiNPs, little is known
about how this material interacts with specific cellular
Fig. 5 SiNPs inhibit activation of mouse TRPV4 heterologously expressed in HEK293T cells. a, b Effects of the TRPV4 agonist GSK1016790A on the
[Ca2+]i in the absence (a, n = 127) or in the presence of 10 μg/ml SiNPs (b, n = 243). The thick continuous traces correspond to the average
responses and the thin dashed traces correspond to the mean plus/minus the standard errors. The black and grey traces correspond to cells with
high or low basal [Ca2+]i, respectively (see text). c Concentration-dependent effects on SiNPs on the intracellular Ca
2+ levels in cells with low and
high basal Ca2+. d Average amplitude of responses to 10 nM GSK1016790A when applied in the presence of SiNPs at different concentrations.
The solid line represents a fit with a Hill function (see Methods). e, f Effects of the TRPV4 agonist 4αPDD on the [Ca2+]i in the absence (a, n = 347)
or in the presence of SiNPs (b, n = 164). The traces are color-coded as in panels (a) and (b)
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components. Under the plausible assumption that SiNPs
interact primarily with the plasma membrane of epithelial
cells, in this study we evaluated the effects on TRPV4, a
cation-permeable channel that is highly enriched in these
cells.
In essence, we found that SiNPs inhibit intracellular
Ca2+ signals triggered by activation of native TRPV4
channels in human and mouse airway epithelial cells.
TRPV4 inhibition by SiNPs was confirmed with Ca2+
imaging and direct measurements of TRPV4 currents in
the heterologous expression system HEK293T. In sharp
contrast to these results, we show that SiNPs enhanced
the activation of TRPV1, demonstrating that these parti-
cles have a specific inhibitory action on TRPV4 chan-
nels. Finally, we found that SiNPs abrogate the increase
in ciliary beat frequency induced by TRPV4 activation in
mouse airway epithelial cells.
The comparison of the data obtained in mTEC and
HEK293T cells transfected with mouse TRPV4 indicate
that SiNPs have very similar effects on the responses to
GSK1016790A, with IC50 values around 1 μg/ml. In con-
trast, SiNPs appeared to be much less effective in
16HBE cells, with a 100-fold higher IC50 value. This may
indicate that human TRPV4 is less sensitive than the
mouse isoform. Nevertheless, the SiNPs concentrations
required to inhibit TRPV4 mediated responses in the
human-derived cells (100 - 3000 μg/ml) are in the same
range or lower than those used in cytotoxicity and cyto-
kine release in vitro experiments performed in previous
studies (25 - 6000 μg/ml [18, 23, 24]. Moreover, we
Fig. 6 The pre-application time of SiNP has no significant effect on the magnitude of inhibition of TRPV4 response to GSK1016790A. a Effects of
the TRPV4 agonist GSK1016790A on the [Ca2+]i of HEK293T cells transfected with mouse TRPV4. b, c, d TRPV4 responses to GSK1016790A after
pre-application of SiNPs during different periods (0, 3 and 10 min for panels b, c and d, respectively). The thick continuous traces correspond to
the average responses and the thin dashed traces correspond to the mean plus/minus the standard errors. The black and grey traces correspond
to cells with high or low basal [Ca2+]i, respectively (see text). e, f Average amplitude of responses to 2 min applications of GSK1016790A in control
and after pre-application of SiNPs for different periods (n = 105 - 385)
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observed the inhibitory effect on TRPV4 in a matter of
minutes, which represents a time scale 3- to 150-fold
shorter than that of those previous reports. This strongly
suggests TRPV4 as a primary and sensitive target of
SiNPs.
As for the mechanism underlying the effects of SiNPs,
it may be speculated that these particles somehow dis-
rupt the binding site of GSK1016790A. SiNPs are
roughly the same size of the whole channel protein, and
more than twice the size of the length of the channel’s
transmembrane segments. So, it is unlikely that these
nanoparticles interact directly with a relatively small bind-
ing pocket for GSK1016790A, unless this would be lo-
cated on the channel’s outer interface. However, to the
best of our knowledge, the binding site for GSK1016790A
is not yet known. On the other hand, we gained some
insight into this issue from the result that SiNPs also
strongly inhibit TRPV4 activation by 4αPDD, a compound
that was reported to interact with an internal pocket of
the channel formed between transmembrane segments 3
and 4 [44]. Notably, SiNPs also altered the response of
TRPV1 to capsaicin, which was reported to bind to an
Fig. 7 SiNPs inhibit activation of TRPV4 currents in whole-cell patch-clamp recordings. a, b) Experiments in TRPV4-transfected HEK293T cells showing
the effects of the TRPV4 agonist GSK1016790A in the absence (a) and in the presence (b) of SiNPs. The data points represent the amplitude of the
currents measured at -75 and +75 mV. The colored data points correspond to the current traces displayed on the panels shown on the right.
c Average amplitude of currents recorded at -75 and +75 mV during application of SiNPs. For every cell these values were normalized to the amplitude
measured in control condition (n = 3 - 10; * and ** indicate P < 0.05 and P < 0.01, respectively; t test for comparison to 1). d Concentration-dependent
inhibitory effect of SiNPs on the amplitude of TRPV4 currents measured at -75 mV during 1 min application of GSK1016790A. The solid line represents
the fit with a Hill function (see Methods)
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occluded region of this channel [45]. Thus, according to
our reasoning above, SiNPs seem not to act on TRPV4
and TRPV1 activation mechanisms by competitive inhib-
ition. At this point we may just speculate that SiNPs in-
duce mechanical perturbations in the plasma membrane
that may disrupt activation of TRPV4 and enhance activa-
tion of TRPV1.
An interesting observation was that the SiNPs failed to
completely inhibit TRPV4 activation. This could result
from the presence of two channel populations with dis-
tinct sensitivities to SiNPs. This might be the case for
the HEK293T cells, in which an endogenous human
TRPV4 channel population may co-exist with the trans-
fected mouse TRPV4 channels. However, we observed
the lack of complete inhibition also in native 16HBE and
mTEC, for which there is no evidence for separate popu-
lations of TRPV4. Although further studies are required
to address this point, we may also consider that if SiNPs
inhibit channel activation by inducing mechanical per-
turbations in the plasma membrane, these might not be
sufficient to completely silence channel activity.
A concomitant finding in our experiments was that
SiNPs induce an increase in basal [Ca2+]i in the human-
derived cells. However, our data demonstrates that
TRPV4 channels are not involved in this effect (e.g., lack
of inhibitory effect of the TRPV4 blocker HC067047).
This is different from what was previously suggested by
Gilardino et al., who found that the unspecific TRPV
Fig. 8 SiNPs inhibit activation of TRPV4 currents in perforated patch-clamp recordings. a, b Experiments in TRPV4-transfected HEK293T cells showing
the effects of the TRPV4 agonist GSK1016790A in the absence (a) and in the presence (b) of SiNPs. The data points represent the amplitude of the
currents measured at -75 and +75 mV. The colored data points correspond to the current traces displayed on the panels shown on the right.
c Average increase in the amplitude of currents (recorded at -75 and +75 mV) induced by the application of 10 nM GSK1016790A during 2 min,
in the absence (n = 5) and in the presence (n = 6) of 30 μg/ml SiNPs. The * and ** symbols indicate P < 0.05 and P < 0.01; unpaired t test
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channel blocker ruthenium red inhibited intracellular
Ca2+ responses to SiNPs [38]. A possible cause for this is
that these authors used particles of 50 nm in diameter,
which represents about a 170-fold larger volume than
that of the ones we used here. Considering that TRPV4
can be activated by mechanical stress at the plasma
membrane [39, 46], it is conceivable that only the larger
particles may induce TRPV4 activation. On the other
hand, Gilardino et al. [38] did find TRPV4-independent
responses to SiNPs, which could be triggered via mecha-
nisms similar to those underlying the responses we
found in 16HBE cells and in HEK293T cells displaying
low basal Ca2+ concentration. Of note, for some yet
unclear reasons mTEC did not display Ca2+ responses
upon SiNPs application.
Other features of our results are also qualitatively
comparable to those obtained by Gilardino et al. [38].
For instance, the intracellular Ca2+ responses to SiNPs
occurred after a significant delay and showed a transient
initial phase (Fig. 2b). The mechanisms underlying these
responses remain fully unknown, but could be related to
Ca2+ release from intracellular stores. However, the fact
that we found SiNPs to increase inward and outward
basal currents in HEK293T cells is more consistent with
enhanced activities of Ca2+-permeable channels in the
plasma membrane (e.g., the ubiquitously expressed
TRPM7 channels) [47]. These mechanisms should be
addressed in future studies because they may bare
relevance for the toxic effects of SiNPs (Ca2+ overload)
in airway epithelial cells.
Conclusions
Our results show that SiNPs inhibit TRPV4 activation,
and that this effect may impair the positive modulatory
action of the stimulation of this channel on the ciliary
function in airway epithelial cells. It has been proposed
that inhibition of TRPV4 could have therapeutic benefits
in several respiratory conditions, such as chronic heart
failure, hypoxia-induced pulmonary hypertension, acute
lung injury, chronic obstructive pulmonary disease and
cough [48–51]. However, TRPV4 activity has been
shown to underlie protective responses in airway epithe-
lial cells, including the increase in CBF [26, 43]. In
addition, TRPV4 function was reported to be important
for essential functions in other cells that are direct tar-
gets of polluting SiNPs. These include the enhancement
Fig. 9 Effects of SiNPs on the capsaicin receptor TRPV1. a, b Effects of the TRPV1 agonist capsaicin on the [Ca2+]i of HEK293T cells transfected
with mouse TRPV1, in the absence (a, n = 200) or in the presence of SiNPs (b, n = 68). The thick continuous traces correspond to the average
responses and the thin dashed traces correspond to the mean plus/minus the standard errors
Fig. 10 SiNPs inhibit the increase in ciliary beat frequency induced by activation of TRPV4 in mTEC. a Increase of CBF induced by application of
the TRPV4 agonist GSK1016790A. b Lack of effect of GSK1016790A on the CBF in the presence of SiNPs
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of barrier function is skin keratynocytes [52, 53],
endothelium-dependent vasorelaxation in pulmonary
arteries [54], and ATP release from oesophageal keraty-
nocytes [55]. Thus, inhibition of TRPV4 by SiNPs is
expected to have complex effects on airway pathophysi-
ology and rather certain detrimental effects on several
epithelial cell functions. Our findings unveil TRPV4
and TRPV1 as defined molecular targets of SiNPs, and
prompt for further exploration of the role of these
channels in the cellular effects of other types of par-
ticulate matter.
Acknowledgements
The authors would like to thank Prof. Bernd Nilius and the members of the
LICR laboratory for helpful discussions and to Melissa Benoit for the
maintenance of the cell cultures.
Availability of data and materials
All data generated or analysed during this study are included in this
published article
Funding
Y.A.A. held a Postdoctoral Mandate of the KU Leuven and is currently a
Postdoctoral Fellow of the Fund for Scientific Research Flanders (FWO).
Research was supported by grants from the Research Foundation Flanders
FWO (G076714), the Research Council of the KU Leuven (Grants GOA/14/011
and PF-TRPLe), The Spanish Ministry of Economy and Competitiveness
(SAF2015-69762R and María de Maeztu Programme for Units of Excellence in
R&D MDM-2014-0370), and the FEDER Funds.
Authors' contributions
AS, KD and YAA performed Ca2+ imaging experiments; AS, JLA and JAC
performed the patch-clamp experiments; CJ performed the CBF measurements;
SMC performed the characterization of the particles; MAV, PHH and KT super-
vised the project; AS and KT wrote the manuscript. All authors edited the manu-
script, and have given approval to its final version.
Ethics approval
Experiments were performed in accordance with the guidelines established
by the European Communities Council Directive (86/609/ECC) and by the
Ethics Committee of the KU Leuven, Leuven (021/2012).
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Cellular and Molecular Medicine, Laboratory of Ion Channel
Research, KU Leuven; VIB Center for Brain & Disease Research, Leuven,
Belgium. 2Department of Experimental and Health Sciences, Laboratory of
Molecular Physiology and Channelopathies, Universitat Pompeu Fabra,
Barcelona, Spain. 3KU Leuven BIOMAT, Department of Oral Health Sciences,
KU Leuven & Dentistry University Hospitals Leuven, Leuven, Belgium.
4Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.
5Present address: Department of Cardiovascular Sciences, Laboratory of
Experimental Cardiology, Leuven, KU, Belgium.
Received: 5 May 2017 Accepted: 27 October 2017
References
1. Fede C, Selvestrel F, Compagnin C, Mognato M, Mancin F, Reddi E, et
al. The toxicity outcome of silica nanoparticles (Ludox®) is influenced by
testing techniques and treatment modalities. Anal. Bioanal. Chem. 2012;
404:1789–802.
2. Fede C, Millino C, Pacchioni B, Celegato B, Compagnin C, Martini P, et al.
Altered gene transcription in human cells treated with ludox® silica
nanoparticles. Int. J. Environ. Res. Public Health. 2014;11:8867–90.
3. Napierska D, Thomassen LCJ, Rabolli V, Lison D, Gonzalez L, Kirsch-Volders
M, et al. Size-dependent cytotoxicity of monodisperse silica nanoparticles in
human endothelial cells. Small. 2009;5:846–53.
4. Napierska D, Quarck R, Thomassen LCJ, Lison D, Martens J. a, Delcroix M, et
al. Amorphous silica nanoparticles promote monocyte adhesion to human
endothelial cells: size-dependent effect. Small. 2012;9:1–9.
5. Vance ME, Kuiken T, Vejerano EP, McGinnis SP, Hochella MF, Rejeski D, et al.
Nanotechnology in the real world: Redeveloping the nanomaterial
consumer products inventory. Beilstein J. Nanotechnol. 2015;6:1769–80.
6. Kettiger H, Schipanski A, Wick P, Huwyler J. Engineered nanomaterial
uptake and tissue distribution: from cell to organism. Int. J. Nanomedicine.
2013;8:3255–69.
7. Al-Rawi M, Diabaté S, Weiss C. Uptake and intracellular localization of
submicron and nano-sized SiO2 particles in HeLa cells. Arch. Toxicol.
2011;85:813–26.
8. Thomassen LCJ, Rabolli V, Masschaele K, Alberto G, Tomatis M, Ghiazza M, et
al. Model system to study the influence of aggregation on the hemolytic
potential of silica nanoparticles. Chem. Res. Toxicol. 2011;24:1869–75.
9. Yu P, Li J, Jiang J, Zhao Z, Hui Z, Zhang J, et al. A dual role of transient
receptor potential melastatin 2 channel in cytotoxicity induced by silica
nanoparticles. Sci. Rep. 2015;5:18171.
10. Ahmad J, Ahamed M, Akhtar MJ, Alrokayan SA, Siddiqui MA, Musarrat J, et
al. Apoptosis induction by silica nanoparticles mediated through reactive
oxygen species in human liver cell line HepG2. Toxicol. Appl. Pharmacol.
Elsevier Inc. 2012;259:160–8.
11. Kim I-Y, Joachim E, Choi H, Kim K. Toxicity of silica nanoparticles depends
on size, dose, and cell type. Nanomedicine Nanotechnology, Biol. Med.
Elsevier Inc. 2015;11:1407–16.
12. Sun L, Li Y, Liu X, Jin M, Zhang L, Du Z, et al. Cytotoxicity and
mitochondrial damage caused by silica nanoparticles. Toxicol. Vitr.
Elsevier Ltd. 2011;25:1619–29.
13. Nagakura C, Negishi Y, Tsukimoto M, Itou S, Kondo T, Takeda K, et al.
Involvement of P2Y11 receptor in silica nanoparticles 30-induced IL-6
production by human keratinocytes. Toxicology. Elsevier Ireland Ltd.
2014;322:61–8.
14. Corbalan JJ, Medina C, Jacoby A, Malinski T, Radomski MW. Amorphous
silica nanoparticles trigger nitric oxide/peroxynitrite imbalance in human
endothelial cells: inflammatory and cytotoxic effects. Int. J. Nanomedicine.
2011;6:2821–35.
15. Stępnik M, Arkusz J, Smok-Pieniążek A, Bratek-Skicki A, Salvati A, Lynch I, et
al. Cytotoxic effects in 3T3-L1 mouse and WI-38 human fibroblasts following
72 hour and 7 day exposures to commercial silica nanoparticles. Toxicol.
Appl. Pharmacol. 2012;263:89–101.
16. Guo C, Xia Y, Niu P, Jiang L, Duan J, Yu Y, et al. Silica nanoparticles induce
oxidative stress, inflammation, and endothelial dysfunction in vitro via
activation of the MAPK/Nrf2 pathway and nuclear factor-κB signaling. Int. J.
Nanomedicine. 2015;10:1463–77.
17. Ariano P, Zamburlin P, Gilardino A, Mortera R, Onida B, Tomatis M, et
al. Interaction of spherical silica nanoparticles with neuronal cells: Size-
dependent toxicity and perturbation of calcium homeostasis. Small.
2011;7:766–74.
18. Kasper J, Hermanns MI, Bantz C, Maskos M, Stauber R, Pohl C, et al.
Inflammatory and cytotoxic responses of an alveolar-capillary coculture
model to silica nanoparticles: comparison with conventional monocultures.
Part. Fibre Toxicol. BioMed Central Ltd. 2011;8:6.
19. Hofmann F, Bläsche R, Kasper M, Barth KA. Co-culture system with an
organotypic lung slice and an immortal alveolar macrophage cell line to
quantify silica-induced inflammation. PLoS One. 2015;10:e0117056.
20. Marchiando AM, Graham WV, Turner JR. Epithelial barriers in homeostasis
and disease. Annu. Rev. Pathol. 2010;5:119–44.
Sanchez et al. Particle and Fibre Toxicology  (2017) 14:43 Page 13 of 14
21. Ganesan S, Comstock AT, Sajjan US. Barrier function of airway tract
epithelium. Tissue barriers. 2013;1:e24997.
22. Satir P, Sleigh MA. The physiology of cilia and mucociliary interactions.
Annu. Rev. Physiol. 1990;52:137–55.
23. Rabolli V, Badissi A, Devosse R, Uwambayinema F, Yakoub Y, Palmai-Pallag
M, et al. The alarmin IL-1α is a master cytokine in acute lung inflammation
induced by silica micro- and nanoparticles. Part. Fibre Toxicol. 2014;11:69.
24. Skuland T, Ovrevik J, Låg M, Schwarze P. Refsnes M. Silica nanoparticles
induce cytokine responses in lung epithelial cells through activation of a
p38/TACE/TGF-α/EGFR-pathway and NF-κΒ signalling. Toxicol. Appl.
Pharmacol. Elsevier Inc. 2014;279:76–86.
25. Delaval M, Boland S, Solhonne B, Nicola M-A, Mornet S, Baeza-Squiban A, et
al. Acute exposure to silica nanoparticles enhances mortality and increases
lung permeability in a mouse model of Pseudomonas aeruginosa
pneumonia. Part. Fibre Toxicol. 2015;12:1.
26. Lorenzo IM, Liedtke W, Sanderson MJ, Valverde MA. TRPV4 channel
participates in receptor-operated calcium entry and ciliary beat frequency
regulation in mouse airway epithelial cells. Proc. Natl. Acad. Sci. U. S. A.
2008;05:12611–6.
27. Andrade YN, Fernandes J, Lorenzo IM, Arniges M, Valverde MA. The TRPV4
channel in ciliated epithelia. In: TRP Ion Channel Function in Sensory
Transduction and Cellular Signaling Cascades. Liedtke WB, Heller S, editors.
Boca Raton: CRC Press/Taylor & Francis; 2007. Chapter 30.
28. Alvarez DF, King JA, Weber D, Addison E, Liedtke W, Townsley MI. Transient
receptor potential vanilloid 4-mediated disruption of the alveolar septal
barrier: A novel mechanism of acute lung injury. Circ. Res. 2006;99:988–95.
29. Cioffi DL, Lowe K, Alvarez DF, Barry C, Stevens T. TRPing on the lung
endothelium: calcium channels that regulate barrier function. Antioxid.
Redox Signal. 2009;11:765–76.
30. Li J, Kanju P, Patterson M, Chew W-L, Cho S-H, Gilmour I, et al. TRPV4-
mediated calcium influx into human bronchial epithelia upon exposure to
diesel exhaust particles. Environ. Health Perspect. 2011;119:784–93.
31. Nilius B, Owsianik G, Voets T, Peters J A. Transient receptor potential cation
channels in disease. Physiol. 2007; Vol.87.
32. Bhargave G, Woodworth BA, Xiong G, Wolfe SG, Antunes MB, Cohen NA.
Transient receptor potential vanilloid type 4 channel expression in chronic
rhinosinusitis. Am. J. Rhinol. 22:7–12.
33. Goldenberg NM, Ravindran K, Kuebler WM. TRPV4: physiological role and
therapeutic potential in respiratory diseases. Naunyn. Schmiedebergs. Arch.
Pharmacol. 2014;388:421–36.
34. Meseguer VM, Denlinger BL, Talavera K. Methodological considerations to
understand the sensory function of TRP channels. Curr. Pharm. Biotechnol.
2011;12:3–11.
35. Andrade YN, Fernandes J, Vázquez E, Fernández-Fernández JM, Arniges M,
Sánchez TM, et al. TRPV4 channel is involved in the coupling of fluid
viscosity changes to epithelial ciliary activity. J. Cell Biol. 2005;168:869–74.
36. Fernández-Fernández JM, Nobles M, Currid A, Vázquez E, Valverde MA, Maxi
K+ channel mediates regulatory volume decrease response in a human
bronchial epithelial cell line. Am. J. Physiol. Cell Physiol. 2002;283:C1705–14.
37. Fernández-Fernández JM, Andrade YN, Arniges M, Fernandes J, Plata C,
Rubio-Moscardo F, et al. Functional coupling of TRPV4 cationic channel and
large conductance, calcium-dependent potassium channel in human
bronchial epithelial cell lines. Pflügers Arch. 2008;457:149–59.
38. Gilardino A, Catalano F, Ruffinatti FA, Alberto G, Nilius B, Antoniotti S, et al.
Interaction of SiO2 nanoparticles with neuronal cells: Ionic mechanisms
involved in the perturbation of calcium homeostasis. Int. J. Biochem. Cell
Biol. Elsevier Ltd. 2015;66:101–11.
39. Alpizar YA, Sanchez A, Radwan A, Radwan I, Voets T, Talavera K. Lack of
correlation between the amplitudes of TRP channel-mediated responses to
weak and strong stimuli in intracellular Ca2+ imaging experiments. Cell
Calcium. Elsevier Ltd. 2013;54:362–74.
40. Everaerts W, Zhen X, Ghosh D, Vriens J, Gevaert T, Gilbert JP, et al. Inhibition
of the cation channel TRPV4 improves bladder function in mice and rats
with cyclophosphamide-induced cystitis. J. Urol. 2011;186:753.
41. Fernandes J, Lorenzo IM, Andrade YN, Garcia-Elias A, Serra SA, Fernández-
Fernández JM, et al. IP3 sensitizes TRPV4 channel to the mechano-and
osmotransducing messenger 5'-6'-epoxyeicosatrienoic acid. J. Cell Biol.
2008;181:143–55.
42. Balakrishna S, Song W, Achanta S, Doran SF, Liu B, Kaelberer MM, et al.
TRPV4 inhibition counteracts edema and inflammation and improves
pulmonary function and oxygen saturation in chemically induced acute
lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2014;307:L158–72.
43. Alenmyr L, Uller L, Greiff L, Högestätt ED, Zygmunt PM. TRPV4-mediated
calcium influx and ciliary activity in human native airway epithelial cells.
Basic Clin. Pharmacol. Toxicol. 2014;114:210–6.
44. Vriens J, Owsianik G, Janssens A, Voets T, Nilius B. Determinants of 4 alpha-
phorbol sensitivity in transmembrane domains 3 and 4 of the cation
channel TRPV4. J Biol Chem. 2007;282:12796–803.
45. Cao E, Liao M, Cheng Y, Julius D. TRPV1 structures in distinct conformations
reveal activation mechanisms. Nature. 2013;504:113–8.
46. Watanabe H, Vriens J, Janssens A, Wondergem R, Droogmans G, Nilius B.
Modulation of TRPV4 gating by intra- and extracellular Ca2+. Cell Calcium.
2003;33:489–95.
47. Fleig A, Chubanov V. TRPM7. In: Mamm. Transient Recept. Potential Cation
Channels Vol. I. Nilius B, Flockerzi V, editors. Berlin, Heidelberg: Springer
Berlin Heidelberg; 2014. pp. 521–46.
48. Bonvini SJ, Birrell MA, Smith JA, Belvisi MG, Targeting TRP. channels for
chronic cough: From bench to bedside. Naunyn. Schmiedebergs. Arch.
Pharmacol. 2015;388:401–20.
49. Goldenberg N, Wang L, Ranke H, Tabuchi A, Kuebler WM. TRPV4 Channel
Activity Is Required For Hypoxic Pulmonary Vasoconstriction.
Anesthesiology. 2005;122(6):1338–48.
50. Grace MS, Baxter M, Dubuis E, Birrell MA, Belvisi MG. Transient receptor
potential (TRP) channels in the airway: Role in airway disease. Br. J.
Pharmacol. 2014;171:2593–607.
51. Loot AE, Popp R, Fisslthaler B, Vriens J, Nilius B, Fleming I. Role of
cytochrome P450-dependent transient receptor potential V4 activation in
flow-induced vasodilatation. Cardiovasc. Res. 2008;80:445–52.
52. Sokabe T, Fukumi-Tominaga T, Yonemura S, Mizuno A, Tominaga M. The
TRPV4 channel contributes to intercellular junction formation in
keratinocytes. J. Biol. Chem. 2010;285:18749–58.
53. Kida N, Sokabe T, Kashio M, Haruna K, Mizuno Y, Suga Y, et al. Importance
of transient receptor potential vanilloid 4 (TRPV4) in epidermal barrier
function in human skin keratinocytes. Pflugers. Arch. Eur. J. Physiol. 2012;
463:715–25.
54. Sukumaran SV, Singh TU, Parida S, Narasimha Reddy CE, Thangamalai R,
Kandasamy K, et al. TRPV4 channel activation leads to endothelium-
dependent relaxation mediated by nitric oxide and endothelium-derived
hyperpolarizing factor in rat pulmonary artery. Pharmacol. Res. Elsevier Ltd.
2013;78:18–27.
55. Mihara H, Boudaka A, Sugiyama T, Moriyama Y, Tominaga M. Transient
receptor potential vanilloid 4 (TRPV4)-dependent calcium influx and ATP
release in mouse oesophageal keratinocytes. J. Physiol. 2011;589:3471–82.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Sanchez et al. Particle and Fibre Toxicology  (2017) 14:43 Page 14 of 14
